Assessment of the Maximal Tolerated Dose of a Microencapsulated Grass (Phleum pratense) Pollen Extract (MGPE) in Subjects with Grass Pollen Allergy in a Randomized, Double-Blind, Placebo-Controlled Study.
Phase of Trial: Phase I/II
Latest Information Update: 07 Jul 2011
At a glance
- Drugs Grass pollen allergy immunotherapy (Primary)
- Indications Allergic rhinitis; Grass pollen hypersensitivity
- Focus Adverse reactions; Pharmacodynamics
- 07 Jul 2011 New trial record